本报道最初发表于Endpoints News。请点击这里查看原文
Backlash is brewing against a sweeping overhaul of Germany’s health insurance system as Eli Lilly and Boehringer Ingelheim slash investment in the country.
在德国针对其医疗保险体系的大规模改革酝酿强烈反弹之际,礼来(Eli Lilly)和勃林格殷格翰(Boehringer Ingelheim)正大幅削减在德国的投资。
您已阅读5%(268字),剩余95%(5217字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。